Shortly before the government-funding bill passed, Republican strategist Doug Heye said there simply wasn’t enough time to ...

Reports that cows have been infected despite farmers' preventive measures indicate there are multiple routes of transmission ...

To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to ...

We may have an answer to the “mystery illness” in the Democratic Republic of Congo. Here's what the story reveals about ...

The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.

House lawmakers voted 366-34 to pass a spending bill on Friday. The Senate passed it on a 85-11 vote. The bill, which funds ...

After two recent deaths in gene therapy clinical trials, the industry needs to be more open to sharing information to protect ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A major report on alcohol's effects contradicts recent studies in finding that moderate drinkers had lower mortality.

New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way ...

The treatment, called CagriSema, led patients to lose 20% of their weight at 68 weeks in a late-stage study when looking at ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...